单孔机器人辅助剑突下入路胸腺切除术安全性与性能的初步评估
本研究为前瞻性、多中心、单臂临床研究,评估达芬奇单孔(SP)手术系统经剑突下小切口行胸腺切除术的性能与安全性。在美国6个中心纳入13例患者(良性6例,恶性7例),所有手术均完成且无中转,恶性病例R0切除率100%,未发生术中或严重不良事件。结论认为该术式可行,早期无安全性担忧。
要点
- 单孔机器人剑突下胸腺切除术在13例患者中全部完成,无中转。
- 恶性病例完整切除率达100%,无术中或严重不良事件。
- 平均剑突下切口仅3.8 cm,提示创伤较小。
核心结论
- 经剑突下入路使用达芬奇SP系统行胸腺切除术是可行的,早期未显示安全性或操作相关担忧。
研究设计与样本
- 前瞻性、多中心、单臂临床研究,在美国6个中心纳入13例患者(良性6例,恶性7例)。
- 主要性能终点为获得R0切除及无中转完成手术的能力;主要安全终点为术后30天内所有不良事件。
主要发现
- 所有单孔胸腺切除术均通过平均3.8 cm的剑突下小切口完成,未中转其他微创或开放术式。
- 恶性病例完整切除率为100%。
- 无参与者发生术中或严重不良事件,未报告非预期器械不良效应。
关键数值与推荐
- R0切除率:恶性病例为100%。
- 平均切口长度:3.8 cm。
- 无中转率:全部13例均无中转。
- 严重不良事件:0例。
临床怎么用
- 对于适合微创胸腺切除的患者,剑突下单孔机器人手术可作为潜在术式选择,但需在具备SP系统的中心开展。
- 该术式允许双侧纵隔视野,可能减少疼痛,但需更大样本验证其相对多孔机器人手术的优势。
局限性
- 单臂设计、样本量小(13例),缺乏与多孔机器人或开胸手术的对照。
- 随访时间短,仅报告术后30天内安全性。
- 结论需更大规模临床研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sternotomy is the traditional approach for thymectomy. However, over the last 2 decades, minimally invasive surgical approaches (multiport thoracoscopic and robotic-assisted surgery) have proven feasible, offering similar survival, lower morbidity, and shorter length of stay. Single-port (SP) subxiphoid thymectomy potentially offers less pain and allows bilateral visualization of the mediastinum. METHODS: A prospective, multicenter, single-arm clinical study was conducted to evaluate the performance and safety of the da Vinci SP surgical system (Intuitive) for thymectomy through a subxiphoid incision. Primary performance end points included ability to achieve R0 resection and completion of the procedure without conversion. The primary safety end point was all adverse events up to 30 days postoperatively. RESULTS: The study enrolled 13 individuals (benign, n = 6; malignant, n = 7) at 6 centers in the United States. All SP thymectomy procedures were completed through a small (mean, 3.8 cm) subxiphoid incision without conversion to other minimally invasive or open approaches. For malignant cases, the rate of complete resection was 100%. No study participants experienced any intraoperative or serious adverse events. No unanticipated adverse device effects were reported. CONCLUSIONS: Thymectomy using the da Vinci SP surgical system through a subxiphoid approach is feasible, and there are no early indications of safety or procedural concerns. Larger clinical studies are warranted to further evaluate the relative benefits and limitations of the SP system compared with multiport robotic thymectomy.
引用
- Marshall MB, Wee JO, Soukiasian HJ, et al. Initial Evaluation of the Safety and Performance of Single-Port Robotic-Assisted Thymectomy Through a Subxiphoid Incision. Ann Thorac Surg. 2024. PMID: 39667479. doi:10.1016/j.athoracsur.2024.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。